SPI-62: Clinical Trials

3 trials of SPI-62, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1

Follow SPI-62: new trials by email Literature Review of SPI-62 trials Research Report on SPI-62

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
clofutriben, Placebo - Type 2 Diabetes, Cortisol Excess
Phase 2RecruitingSparrow Pharmaceuticals15002025-11-292026-10-06
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
SPI-62, Placebo - Cushing's Syndrome I, Cushing Disease Due to Increased ACTH Secretion
Phase 2CompletedSparrow Pharmaceuticals262022-09-012025-10-08
A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)
SPI-62, SPI-62 matched placebo, Prednisolone 10mg - Polymyalgia Rheumatica
Phase 2CompletedSparrow Pharmaceuticals662022-07-222025-05-11

Conditions studied

ACTH Syndrome, Ectopic (2)  ·  Cushing Syndrome (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Pituitary ACTH Hypersecretion (1)  ·  Polymyalgia Rheumatica (1)

Sponsors

Sparrow Pharmaceuticals (3)

Countries

United States (2)  ·  Bulgaria (1)  ·  Germany (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

David Katz (1)  ·  Frank Czerwiec, MD (1)